• News

News

Stay up-to-date. In our news section we regularly inform you about the latest news from HWI group.

Unexpected quality problems in pharmaceutical manufacturing require a reliable root cause analysis as well as quality and safety assessment followed by the definition of preventive measures to avoid such incidents.

Find out what this means in detail in our HWI-blog by Dr Sandra Huertgen.

30 years ago: On January 8th, 1991, the company was founded by Dr. Stefan Wissel and Prof. Dr. Hanns Häberlein. The two university friends created the name HWI from the first letters of their last names.

#PressRelease

As of January 1st, 2021, Dr Frank Böttcher will be appointed to the management team of HWI pharma services GmbH and will strengthen the current management team of Dr Stefan Wissel and Dr Melanie Kerst.

You will find further information in our press release.

At the end of the year we look back on eventful, challenging and extraordinary months. Therefore, we would like to thank you very much for the good and successful cooperation with you!

The term "nano" seems to be omnipresent. These are particles that are smaller than a millionth of a meter in diameter. As tiny as they are, nanoparticles offer great potential for humans, nature and technology.

What role nanoparticles play in the pharmaceutical industry can be read in our latest HWI-blog von Philipp Wissel.

Enter our 360° Cleanroom here: 360° Cleanroom. Be right in the middle and take a look behind the scenes!

In our media centre you will find matching films about tableting under containment as well as the production and lyophilization of a nanosuspension.

Digitisation is more than  the introduction of new tools. Data protection, regulatory requirements, AI algorithms, above all "trust and values" play a major role.

Read more in our latest HWI-blog by Thomas Bögel why a good digitization strategy and AI are the pillars for standardization and quality improvement.

Hotline

Monday - Friday

+49 7272 7767-0